Reshaping
Diagnostics
Changing and improving the method and efficiency through innovative technologies to reshaping diagnostics for everyone at everywhere with high quality medical services.

News
Unlock a new era in blood diagnostics with Ozelle’s EHBT-75 Analyzer
Ozelle proudly introduces EHBT-75, a revolutionary 7-Diff Auto Hematology Analyzer designed to empower clinical healthcare with AI-driven precision, delivering deeper,
FDA-Clearance for HemoScreen Direct Capillary Sampling
This recent FDA clearance has finally brought HemoScreen to its full potential as a true POC hematology analyzer with its
Ozelle Shenzhen Office Officially Opens
With deep expertise in medical diagnostics, Ozelle is dedicated to delivering innovative and high-precision solutions. From our headquarters in Germany,
Ozelle shines at Medlab Middle East 2025, showcasing cutting-edge AI-Powered POCT solutions
On February 6th, Medlab Middle East 2025 concluded successfully at the Dubai World Trade Center. As one of the most
Reducing Emergency Department Wait Times with Point-of-Care CBC Testing
Emergency departments today are at a breaking point. With patient volumes climbing and staff stretched thin, long wait times have
Unlock a new era in blood diagnostics with Ozelle’s EHBT-75 Analyzer
Ozelle proudly introduces EHBT-75, a revolutionary 7-Diff Auto Hematology Analyzer designed to empower clinical healthcare with AI-driven precision, delivering deeper,
FDA-Clearance for HemoScreen Direct Capillary Sampling
This recent FDA clearance has finally brought HemoScreen to its full potential as a true POC hematology analyzer with its
Ozelle Shenzhen Office Officially Opens
With deep expertise in medical diagnostics, Ozelle is dedicated to delivering innovative and high-precision solutions. From our headquarters in Germany,
Ozelle shines at Medlab Middle East 2025, showcasing cutting-edge AI-Powered POCT solutions
On February 6th, Medlab Middle East 2025 concluded successfully at the Dubai World Trade Center. As one of the most
Reducing Emergency Department Wait Times with Point-of-Care CBC Testing
Emergency departments today are at a breaking point. With patient volumes climbing and staff stretched thin, long wait times have
Reshaping Diagnostics
for Everyone Everywhere
Changing and improving the method and efficiency through innovative technologies to reshaping diagnostics for everyone at everywhere with high quality medical services.
Our History
Our history traced back to 2014, when a research team composed of postdoctoral fellows and scientists from multiple prestigious universities and institutions in the United States, including two postdoctoral fellows from the Lawrence Berkeley National Laboratory, a postdoctoral fellow from the California Department of Public Health, a professor from McMaster University, as well as Dr. Joshua Robinson and Academician Hongjie Dai from the U.S. National Academy of Sciences, was established in Joinn Innovation Park, located in the heart of Silicon Valley, California, USA. In the same year of November, we had research cooperation with Nirmidas and StartX (Stanford’s Accelerator) on Personal and Portable Health Diagnostic Testing. In the following year, our first colloidal analyzer passed the test from DCN, the authorized device test organization in the US.
2014
Our research and development continued in the next few years with encouraging results by steady progress. In 2016, we developed colloidal gold test strip product antibodies in collaboration with ProMab and 2 patents obtained in the same year. In the next 3 years, we updated the version each year from Colloidal analyzer 2.0 version, Second Generation of colloidal analyzer: EHB-2.3 to version EHB3.0-EBH3.1.
2016
When the COVID pandemic prevailed in 2020, our core team decided to move back to Germany. The R&D continued until our first hematology analyzer based on cell morphology technology came alive in 2021. Our brand story started by then…
2021
Our History
Our history traced back to 2014, when a research team composed of postdoctoral fellows and scientists from multiple prestigious universities and institutions in the United States, including two postdoctoral fellows from the Lawrence Berkeley National Laboratory, a postdoctoral fellow from the California Department of Public Health, a professor from McMaster University, as well as Dr. Joshua Robinson and Academician Hongjie Dai from the U.S. National Academy of Sciences, was established in Joinn Innovation Park, located in the heart of Silicon Valley, California, USA. In the same year of November, we had research cooperation with Nirmidas and StartX (Stanford’s Accelerator) on Personal and Portable Health Diagnostic Testing. In the following year, our first colloidal analyzer passed the test from DCN, the authorized device test organization in the US.
Our research and development continued in the next few years with encouraging results by steady progress. In 2016, we developed colloidal gold test strip product antibodies in collaboration with ProMab and 2 patents obtained in the same year. In the next 3 years, we updated the version each year from Colloidal analyzer 2.0 version, Second Generation of colloidal analyzer: EHB-2.3 to version EHB3.0-EBH3.1.
When the COVID pandemic prevailed in 2020, our core team decided to move back to Germany. The R&D continued until our first hematology analyzer based on cell morphology technology came alive in 2021. Our brand story started by then…
Multi-Application Scenarios
Multi-application scenarios refer to situations where a system or technology is designed to be used across various contexts or applications. This requires the system to be versatile and adaptable to meet the diverse needs of different use cases.
Hospital
Laboratory
Clinic
Our Advantages
AI Reshaping Diagnostics
Powered by image recognition and deep learning, our AI generates morphology reports within 6 minutes, accurately identifying abnormal cells and redefining hematology diagnostics with trusted clinical insights.
Maintenance-Free
With an innovative no-liquid pipeline design, our analyzers require no daily cleaning and eliminate clogging risks. Single-use dry reagent cards need no cold-chain storage, cutting maintenance costs and saving time and labor.
Multi-Functional Integration
One analyzer integrates CBC, immunoassay, dry biochemistry, urine, and feces testing. Versatile across clinics, pharmacies, ERs, research labs, and veterinary practices, it delivers true all-in-one functionality.
Globally Validated
Headquartered in Germany with R&D and production centers in China and UAE, Ozelle has over 50,000 installations and 40M+ samples tested worldwide, clinically validated against leading international systems.
What People
Say About Us
Our products are popular among doctors around the world.